-
Featured ArticleMay 04, 2022Putting machine learning to work for cancer patients
A research team at JAX is boosting the speed and accuracy of tumor sample image analysis, for multiple cancer types, offering the potential for more targeted treatment direction without additional testing. -
Research HighlightApril 27, 2022Researching innate immune cells and metastatic cancer
Using sophisticated labeling methods, a team led by Professor Karolina Palucka, M.D., Ph.D., and Jan Martinek, Ph.D., analyzed patient samples of metastatic melanoma for further insight into how cancer cells are able to escape immune response and grow elsewhere in the body. -
Blog PostApril 07, 2022New Fellowship at JAX to Unravel the Complexities Between Aging and Cancer
It’s been long recognized that aging is the single biggest risk factor for cancer and that age impacts treatment response. Research is urgently needed to develop a mechanistic understanding of the influence of aging on tumor initiation, progression and tumor response. -
Research HighlightJanuary 26, 2022The consequences of alternative splicing in breast cancer
JAX researchers used long-read mRNA sequencing to catalog all mRNAs in primary breast cancer samples and revealed previously undocumented mRNA isoforms that can change protein function and may contribute to cancer progression and therapy response.
-
Press ReleaseMay 03, 2022JAX announces 2022 recipients of the JAX Scholar awards
The Jackson Laboratory is proud to announce the 2022 recipients of the JAX Postdoctoral Scholar award. Eric Bogenschutz, Jayna Mistry, and Kwondo Kim represent forward-thinking research, proven leadership, and engagement with the scientific community. -
Search MagazineApril 26, 2022Using machine learning to keep an eye on healthy function and disease
JAX scientist Vivek Kumar, Ph.D., is using machine learning to automate and improve analysis of mouse behavior and movement. The new methods have already yielded important biological insights, and they may have even more profound implications for research into human diseases such as ALS, Alzheimer’s disease, and even cancer. -
Featured ArticleFebruary 01, 2022MCGI: A 'game changer' for cancer patients
The Maine Cancer Genomics Initiative is raising awareness of, and access to, advanced genomic treatments all across Maine. -
Research HighlightDecember 13, 2021Examining the immune response to cancer on a genetic level
The V Foundation for Cancer Research has awarded a grant to JAX's Lucas Chang for genetic studies of the immune response to cancer.